13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-06-10 Event 2025-06-06 SEC 0001437749-25-020018 →

Ali Arif Nasir Entero Therapeutics, Inc. GRDX

Stake: 4.90% Shares: 230,900 CUSIP: 33749P408 Class: Common stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 1.03
61,097 shares short · +9.5% vs prior

Other 13D/G Filings on Entero Therapeutics, Inc.

FiledFormFilerStakeShares
2021-02-10 SC Ross Edmund Burke Jr. view →
2020-08-11 SC Ross Edmund Burke Jr. view →
2020-01-29 SC Ross Edmund Burke Jr. view →
2019-01-08 SC Ross Edmund Burke Jr. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →